Concepedia

Erika Dragon

ED

Statistics

Publications

4

Citations

136

H-Index

4

Active since

2014

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

Eli Lilly (United States)

Université Paris Cité

NIHR Leeds Musculoskeletal Biomedical Research Unit

Erika Dragon is an author at Pfizer (United States) specializing in pain management, pain medicine, and medicine.

Publications per year

2014–2023

4

Publications

4

A Randomized Placebo-Controlled Trial of the Anti-Nerve Growth Factor Antibody Tanezumab in Subjects With Cancer Pain Due to Bone Metastasis

Marie Fallon, Maciej Sopata, Erika Dragon et al. · The Oncologist · 2023 · 47 citations · Full text

Medicine, Oncology, Pharmacology +17

Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double‐blind, placebo‐controlled <scp>EIGHT</scp> trial

Christopher R. Chapple, Tim Schneider, François Haab et al. · British Journal of Urology · 2014 · 33 citations

Medicine, Pharmacology, Pharmacotherapy +17

Are pain severity and current pharmacotherapies associated with quality of life, work productivity, and healthcare utilisation for people with osteoarthritis in five large European countries?

Philip G. Conaghan, Michael J. Doane, Dena H. Jaffe et al. · Clinical and Experimental Rheumatology · 2021 · 30 citations · Full text

Medicine, Orthopedic Surgery, Pharmacotherapy +15

Burden of chronic low back pain: Association with pain severity and prescription medication use in five large European countries

Serge Perrot, Michael J. Doane, Dena H. Jaffe et al. · Pain Practice · 2021 · 26 citations · Full text

Nursing, Rehabilitation Medicine, Health Assessment +15

1–4 of 4